Oxygen Therapy Market

Oxygen Therapy Market Summary:

According to Transpire Insights, a detailed research report on the market reflects that the respiratory disorders application segment dominates the Oxygen Therapy Market, accounting for approximately 48.63% of the total share worldwide in 2025. The Oxygen Therapy Market was valued at approximately USD 49.77 billion in 2025 and is projected to reach USD 110.06 billion by 2033, registering a CAGR of 10.43% during 2026–2033. North America leads the market, supported by advanced healthcare infrastructure and increasing demand for oxygen therapy solutions, making it a leading contributor to market development, technological innovation, advanced oxygen delivery systems, expanding manufacturing capabilities, and overall market growth dynamics.

 Market Snapshot

• Market Value (2025): USD 4.1 Billion.
• Expected Market Value (2026): USD 4.4 Billion.
• Estimated Market Value (2033): USD 6.8 Billion.
• Forecast CAGR (2026–2033): 6.42%
• Leading Region in 2025: North America
• Second-largest Region: Europe
• Fastest Growing Region: Asia Pacific

Introduction 

The Oxygen Therapy Market comprises the manufacturing, marketing and use of medical devices and consumables used to provide extra oxygen to patients with low blood oxygen levels. Oxygen concentrators, oxygen cylinders, liquid oxygen systems, delivery devices, masks, cannulas and associated accessories used across hospitals, clinics, & home healthcare settings are a part of the market. Reduced airflow in chronic obstructive pulmonary disease (COPD) can result in persistent breathing problems and decreased oxygen levels making it a major condition associated with long-term oxygen therapy. Oxygen therapy improves patients’ respiratory symptoms, exercise tolerance, daily activities and overall quality of life. The oxygen therapy market is growing due to the increasing incidence of respiratory diseases, rising demand for home-based care, technological advancements in portable oxygen delivery systems, & increased access to healthcare.

 For instance:-

• North America: North America is leading the oxygen therapy market owing to the presence of advanced healthcare infrastructure, high prevalence of respiratory diseases, established reimbursement systems and high adoption of home oxygen therapy.
• Europe The European oxygen therapy market is experiencing robust growth. This growth is being fueled by an aging population, strong healthcare systems, increasing demand for home respiratory care, and improvements in portable oxygen devices.

Key Market Highlights: -

• North America is expected to grow at a rapid CAGR in the Oxygen Therapy Market by holding around 37% of the share during the forecast period.
• Europe is anticipated to hold roughly 27% share of the Oxygen Therapy Market over the predicted timeframe.
• Asia Pacific is anticipated to hold nearly 25%share of the Oxygen Therapy Market over the predicted timeframe.
• By Product Type, the oxygen concentrators dominated the market and holds nearly 38% share in 2025 and is projected to grow at a substantial CAGR during the forecast period.
• By Application, the Chronic Obstructive Pulmonary Disease dominated the market and holds close to 34% share in 2025 and is projected to grow at a substantial CAGR during the forecast period.
• By End User, the Hospitals segment dominated the market and holds about 60% share in 2025 and is projected to grow at a substantial CAGR during the forecast period.
• Medical oxygen infrastructure is being strengthened and supply networks expanded thru health initiatives and government programs, while hospital oxygen-generation capacity is growing and access to oxygen therapy is improving in underserved healthcare markets.

How is Technology Driving Growth in the Oxygen Therapy Market?

Technology is driving the growth of the oxygen therapy market with oxygen delivery systems becoming more portable, efficient, connected and patient friendly. Improved battery performance in advanced portable oxygen concentrators enables greater mobility and treatment at home. Smart flow-control technologies improve the efficiency and comfort of oxygen delivery by tailoring it to the patients’ breathing patterns. Remote monitoring and digital connectivity enable healthcare professionals to track data related to therapy and enable timely intervention. Reliability is further increased with integrated oxygen sensors, alarms and automated safety features supporting long term use, increasing patient confidence and broadening adoption of modern oxygen therapy solutions.

Market Drivers

The Oxygen Therapy Market is driven by the increasing prevalence of chronic respiratory disorders, such as COPD and asthma, which is driving the market for reliable oxygen delivery systems. The increasing trend of home healthcare is propelling the adoption of portable oxygen concentrators as they offer mobility and convenience for long-term therapy.Technology improvements such as lighter weight, better battery performance, intelligent monitoring, and efficient oxygen delivery methods are improving device usability and patient experience. Rising healthcare expenditure, growing respiratory care infrastructure and better reimbursement coverage are some of the other factors driving the market growth. Furthermore, the aging population and the increasing awareness of the treatment of respiratory diseases are generating the consistent demand for the oxygen therapy equipment ly.

For Instance Asia Pacific: Demand for oxygen therapy equipment is booming in the Asia Pacific region. Growth is being fueled by expanding healthcare infrastructure, an uptick in respiratory disorders, a growing elderly population and better access to respiratory care.

Restrain

The high upfront costs of advanced oxygen concentrators, coupled with recurring costs of electricity, accessories, and maintenance, as well as limited insurance coverage, can be a barrier to patient adoption. Stringent medical device regulations and complex approval procedures may also delay the product commercialization. Consistent usage may be influenced by technical problems such as battery life, maintenance of equipment and proper handling requirements. In addition, the availability and accessibility of oxygen therapy equipment may be limited by poor healthcare infrastructure, inadequate oxygen supply networks and supply-chain dependencies for specialized components, especially in emerging and underserved markets.

Analysis of Prices and Consumer Behaviour

The market for oxygen therapy is anticipated to be driven by the demand for sophisticated oxygen therapy equipment, with portable oxygen concentrators expected to hold a substantial share of the market due to their increasing adoption in home healthcare and long-term respiratory care. They are also likely to be more expensive than conventional oxygen cylinders because of the integrated oxygen concentration technology, battery systems, lightweight design and advanced monitoring features. Home-based applications account for about 45% of the demand for oxygen therapy equipment, due to the convenience, portability and consistent treatment capabilities of today’s oxygen delivery systems. Consumer purchasing behavior indicates that 55% of patients and healthcare providers assign the highest value to oxygen delivery reliability, device efficiency, portability and ease of use. Also, 33% of institutional and home healthcare buyers prefer bulk procurement agreements or long-term contracts to reduce equipment acquisition and maintenance costs and ensure a consistent supply of oxygen therapy devices and accessories across healthcare facilities.

Who are the Key Players in the Oxygen Therapy Market and how do they Compete?

To compete in the international market for oxygen therapy, companies must specialize in advanced oxygen delivery technologies, patient-focused solutions and development of , integrated healthcare distribution networks. This kind of competitive approach, based on portable oxygen concentrators, oxygen delivery efficiency, smart monitoring features, energy-efficient systems, & home healthcare integration, not only competes on price but also promotes ongoing product development that helps healthcare providers and patients gain improved treatment reliability, mobility, safety, and convenience.

ResMed is using its market position to develop innovative oxygen concentrators, respiratory care technologies and connected healthcare solutions. Drive DeVilbiss Healthcare is a leader in product innovation and distribution capabilities developing oxygen therapy equipment and respiratory care solutions for hospitals, home healthcare and long-term patient management.Invacare strengthens its position by offering oxygen concentrators and home respiratory care equipment designed to support patient mobility, treatment convenience and long-term oxygen therapy.

Top Companies in the Oxygen Therapy Market

1. Philips Respironics
2. Invacare
3. ResMed
4. Drive DeVilbiss Healthcare
5. CAIRE Inc
6. Chart Industries
7. Inogen
8. OMRON Healthcar
9. GCE Healthcare
10. Fisher & Paykel Healthcare
11. Air Liquide Healthcare
12. Linde Healthcare
13. OxyGo
14. Nidek Medical
15. Precision Medical

Oxygen Therapy Market. Segmentation

The Oxygen Therapy Market share is divided into five categories: By Product Type, By Application, By End User, By Delivery Mode, By Distribution Channel.

The oxygen concentrators dominated the market, accounting for nearly 38% in 2025 and is expected to rise at a significant CAGR during the forecast period.

The Oxygen Therapy Market is by product type into oxygen concentrators, liquid oxygen devices, oxygen cylinders, venturi masks, nasal cannulas, hyperbaric oxygen systems, oxygen accessories, others. Among these, the oxygen concentrators dominated the market, accounting for nearly 38% in 2025 and expected to increase at a significant CAGR during the forecast period. Oxygen concentrators dominate the segment owing to the increasing adoption of home healthcare, portability, continuous oxygen supply, cost-effectiveness and rising demand for long-term respiratory care.

The Chronic Obstructive Pulmonary Disease dominated the market, accounting for close to 34% in 2025, and is expected to rise at a significant CAGR during the forecast period

The Oxygen Therapy Market is segmented by end user into hospitals, homecare settings, ambulatory care centers, specialty clinics, rehabilitation centers, others Among these, the Chronic Obstructive Pulmonary Disease dominated the market, accounting for close to 34% in 2025 and expected to increase at a significant CAGR during the forecast period. COPD is the most common indication due to its high prevalence, chronic oxygen requirements, aging populations and a rising need for long-term respiratory care and oxygen therapy.

The Hospitals segment dominated the market, accounting for about 60% in 2025 and is expected to rise at a significant CAGR during the forecast period.

The Oxygen Therapy Market by end user into hospitals, cancer centers, specialty clinics, research institutes, ambulatory surgical centers, academic hospitals, others. Among these, the Hospitals segmentdominated the market, accounting for about 60% in 2025 and expected to increase at a significant CAGR during the forecast period. Hospitals are the biggest users of oxygen because they have lots of patients, advanced respiratory care infrastructure, need oxygen for emergencies, and use a lot of specialized oxygen therapy equipment.

Regional Segment Analysis of the Oxygen Therapy Market

• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• North America (U.S., Canada, Mexico) 
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

North America is expected to grow at a rapid CAGR in the Oxygen Therapy Market, holding around 37% of the share during the forecast period.

North America is anticipated to witness significant growth in the Oxygen Therapy Market owing to its advanced healthcare infrastructure, high prevalence of respiratory diseases, favorable reimbursement policies, and increasing adoption of home-based oxygen therapy. There is a strong demand for portable oxygen concentrators, oxygen delivery systems and high tech respiratory care devices in the area. Increasing healthcare expenditure and increasing awareness regarding the management of chronic respiratory diseases are further supporting the market growth. In addition, the regional accessibility is reinforced by existing manufacturers, continuous innovation of products and developed distribution channels. The growing adoption of remote patient monitoring and connected oxygen therapy technologies is also anticipated to boost treatment convenience, thereby supporting sustained demand and market growth across North America.

Europe is the fastest-growing region in the Oxygen Therapy Market during the period, holding roughly 27% share.

Europe is witnessing robust growth in the Oxygen Therapy Market. The growth is driven by aging population, rising cases of chronic respiratory diseases and strong healthcare infrastructure. The demand for portable oxygen concentrators and advanced oxygen delivery systems is projected to increase with the growing adoption of home-based respiratory care. Favorable healthcare reimbursement policies, increasing investments in respiratory care technologies, and growing awareness about oxygen therapy are some of the factors supporting growth in the region. Additionally, technological advancements and enhanced accessibility to specialized respiratory treatment are driving the European oxygen therapy market.

Asia Pacific is the fastest-growing region in the Oxygen Therapy Market during the period, holding nearly 25% share.

The Asia Pacific region is growing fast in the Oxygen Therapy Market. This growth is due to the increase in healthcare infrastructure, chronic respiratory diseases and money spent on healthcare. Demand for oxygen therapy equipment is supported by the growing elderly population and rising awareness of respiratory care.Government initiatives to enhance the availability of medical oxygen and access to healthcare are further fueling the market growth. In addition, the rising adoption of home healthcare, portable oxygen concentrators, and advanced respiratory care technologies is providing lucrative growth opportunities for the market in emerging economies.

Strategies for Market Growth in Non-Leading Regions:

Development of manufacturing technologies for affordable and scalable oxygen therapy equipment would help small to medium-sized healthcare providers and distributors in emerging markets. Local assembly and manufacture of oxygen concentrators, cylinders and oxygen delivery systems, could reduce import dependency and make equipment more affordable overall. Strategic alliances with regional hospitals, home healthcare providers, medical equipment manufacturers and distributors will improve market penetration for oxygen therapy products. Training programs and technical skill development will have to be instituted to improve knowledge of oxygen therapy equipment operation, maintenance, safety and patient management. Moreover, flexible financing, long-term procurement agreements and equipment leasing arrangements can increase the accessibility of oxygen therapy solutions, and incentivize uptake by healthcare providers and patients. The development of collaborative programs with the governments, healthcare organizations, and medical technology providers, along with digital distribution channels, will aid in enhanced accessibility to oxygen therapy equipment and long-term expansion of the market across developing regions.

 Future Market Trends for the Oxygen Therapy Market: -

• Smart Oxygen Therapy: Combining remote monitoring, connected devices, automated oxygen delivery, and digital health technologies to improve treatment management, patient safety, and therapy personalization.
• Portable & Home-Based Care: The rise in home healthcare is increasing the demand for lightweight, battery-efficient portable oxygen concentrators that improve patient mobility, convenience, and long-term treatment adherence.
• Asia-Pacific Expansion: The oxygen therapy market in the Asia-Pacific region is benefiting from a number of favorable factors, including increasing healthcare investments, growing medical infrastructure, increasing prevalence of respiratory diseases, and better access to respiratory care.

Recent Development

• In January 2026: Dräger continued to improve its oxygen therapy solutions with precision flowmeters and pressure-regulation technologies to ensure reliable clinical oxygen delivery.
• In May 2026 Fisher & Paykel Healthcare expanded respiratory-care capabilities and healthcare supply networks to support broader oxygen therapy adoption.

Market Segment

This study forecasts revenue at , regional and country levels from 2020 to 2033. Transpire Insights has segmented the Oxygen Therapy Market based on the below-mentioned segments: 

 Oxygen Therapy Market, By Product Type

• Oxygen Concentrators
• Liquid Oxygen Devices
• Oxygen Cylinders
• Venturi Masks
• Nasal Cannulas
• Hyperbaric Oxygen Systems
• Oxygen Accessories
• Others

 Oxygen Therapy Market, By Application

• COPD
• Asthma
• Sleep Apnea
• Pneumonia
• COVID-19 Recovery
• Cystic Fibrosis
• Emergency Care
• Others

 Oxygen Therapy Market, By End User

• Hospitals
• Homecare Settings
• Ambulatory Care Centers
• Specialty Clinics
• Rehabilitation Centers
• Others

 Oxygen Therapy Market,By Delivery Mode

• Continuous Flow
• Pulse Flow
• Portable Oxygen Systems
• Stationary Systems
• Smart Oxygen Systems
• others

 Oxygen Therapy Market, By Distribution Channel

• Hospital Procurement
• Retail Pharmacies
• Online Retail
• Medical Equipment Distributors
• Direct Sales
• Others

 Oxygen Therapy Market, By Regional Analysis

North America

• US
• Canada
• Mexico

Europe

• Germany
• UK
• France
• Italy
• Spain
• Russia
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• South Korea
• Australia
• Rest of Asia Pacific

South America

• Brazil
• Argentina
• Rest of South America

Middle East & Africa

• UAE
• Saudi Arabia
• Qatar
• South Africa
• Rest of the Middle East & Africa